ONCOS-102

N/A

Report date: 2022/10/10 16:58:55

Base Information

Drug NameONCOS-102
Drug Alias NameCGTG-102ONCOS-102Ad5/3-D24-GMCSF
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulantsImmunostimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsColorectal Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNorwayFrance +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTargovax Oy
China Registration ClassN/A

Develop Information

Inactive CompaniesTargovax Oy
Active IndicationsOvarian NeoplasmsColorectal NeoplasmsAppendiceal Neoplasms
Inactive IndicationsSolid tumoursMelanoma

Other Information

ATC CodeN/A
Related LinksN/A